Literature DB >> 30668551

The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense.

Julie L Horton1, Michael T Davidson2, Clara Kurishima3, Rick B Vega1, Jeffery C Powers3, Timothy R Matsuura4, Christopher Petucci1,4, E Douglas Lewandowski1,5, Peter A Crawford1,6, Deborah M Muoio2, Fabio A Recchia3,7, Daniel P Kelly1,4.   

Abstract

Evidence has emerged that the failing heart increases utilization of ketone bodies. We sought to determine whether this fuel shift is adaptive. Mice rendered incapable of oxidizing the ketone body 3-hydroxybutyrate (3OHB) in the heart exhibited worsened heart failure in response to fasting or a pressure overload/ischemic insult compared with WT controls. Increased delivery of 3OHB ameliorated pathologic cardiac remodeling and dysfunction in mice and in a canine pacing model of progressive heart failure. 3OHB was shown to enhance bioenergetic thermodynamics of isolated mitochondria in the context of limiting levels of fatty acids. These results indicate that the heart utilizes 3OHB as a metabolic stress defense and suggest that strategies aimed at increasing ketone delivery to the heart could prove useful in the treatment of heart failure.

Entities:  

Keywords:  Cardiology; Heart failure; Metabolism; Mitochondria; Mouse models

Mesh:

Substances:

Year:  2019        PMID: 30668551      PMCID: PMC6478419          DOI: 10.1172/jci.insight.124079

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  60 in total

1.  A case of acute decompensated heart failure evaluated by series of exhaled acetone concentrations as noninvasive biomarker of heart failure severity.

Authors:  Tetsuro Yokokawa; Yasuo Sugano; Akito Shimouchi; Atsushi Shibata; Takafumi Nakayama; Takahiro Ohara; Naoya Jinno; Hideaki Kanzaki; Toshihisa Anzai
Journal:  Int J Cardiol       Date:  2015-11-24       Impact factor: 4.164

2.  ATP flux through creatine kinase in the normal, stressed, and failing human heart.

Authors:  Robert G Weiss; Gary Gerstenblith; Paul A Bottomley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

3.  Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; John Newman; Wenjuan He; Kotaro Shirakawa; Natacha Le Moan; Carrie A Grueter; Hyungwook Lim; Laura R Saunders; Robert D Stevens; Christopher B Newgard; Robert V Farese; Rafael de Cabo; Scott Ulrich; Katerina Akassoglou; Eric Verdin
Journal:  Science       Date:  2012-12-06       Impact factor: 47.728

4.  A role for peroxisome proliferator-activated receptor γ coactivator-1 in the control of mitochondrial dynamics during postnatal cardiac growth.

Authors:  Ola J Martin; Ling Lai; Mangala M Soundarapandian; Teresa C Leone; Antonio Zorzano; Mark P Keller; Alan D Attie; Deborah M Muoio; Daniel P Kelly
Journal:  Circ Res       Date:  2013-12-23       Impact factor: 17.367

5.  Mitochondrial protein hyperacetylation in the failing heart.

Authors:  Julie L Horton; Ola J Martin; Ling Lai; Nicholas M Riley; Alicia L Richards; Rick B Vega; Teresa C Leone; David J Pagliarini; Deborah M Muoio; Kenneth C Bedi; Kenneth B Margulies; Joshua J Coon; Daniel P Kelly
Journal:  JCI Insight       Date:  2016-02-25

6.  Insulin, ketone bodies, and mitochondrial energy transduction.

Authors:  K Sato; Y Kashiwaya; C A Keon; N Tsuchiya; M T King; G K Radda; B Chance; K Clarke; R L Veech
Journal:  FASEB J       Date:  1995-05       Impact factor: 5.191

7.  The creatine kinase system in normal and diseased human myocardium.

Authors:  J S Ingwall; M F Kramer; M A Fifer; B H Lorell; R Shemin; W Grossman; P D Allen
Journal:  N Engl J Med       Date:  1985-10-24       Impact factor: 91.245

8.  The Failing Heart Relies on Ketone Bodies as a Fuel.

Authors:  Gregory Aubert; Ola J Martin; Julie L Horton; Ling Lai; Rick B Vega; Teresa C Leone; Timothy Koves; Stephen J Gardell; Marcus Krüger; Charles L Hoppel; E Douglas Lewandowski; Peter A Crawford; Deborah M Muoio; Daniel P Kelly
Journal:  Circulation       Date:  2016-01-27       Impact factor: 29.690

Review 9.  Large animal models of heart failure: a critical link in the translation of basic science to clinical practice.

Authors:  Jennifer A Dixon; Francis G Spinale
Journal:  Circ Heart Fail       Date:  2009-05       Impact factor: 8.790

10.  Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.

Authors:  Lars C Gormsen; Mads Svart; Henrik Holm Thomsen; Esben Søndergaard; Mikkel H Vendelbo; Nana Christensen; Lars Poulsen Tolbod; Hendrik Johannes Harms; Roni Nielsen; Henrik Wiggers; Niels Jessen; Jakob Hansen; Hans Erik Bøtker; Niels Møller
Journal:  J Am Heart Assoc       Date:  2017-02-27       Impact factor: 5.501

View more
  69 in total

1.  Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.

Authors:  Senthil Selvaraj; Daniel P Kelly; Kenneth B Margulies
Journal:  Circulation       Date:  2020-06-01       Impact factor: 29.690

2.  Recommendations for Ramadan fasting to patients with cardiovascular diseases; Turkish Society of Cardiology consensus report.

Authors:  Ahmet Taha Alper; Mehmet Kadri Akboğa; Kazım Serhan Özcan; İstemihan Tengiz; Uğur Önsel Türk; Mustafa Yıldız; Mehmet Birhan Yılmaz; Meral Kayıkçıoğlu; Emine Gazi; Aylin Yıldırır
Journal:  Anatol J Cardiol       Date:  2021-05       Impact factor: 1.596

3.  Exogenous ketones in the healthy heart: the plot thickens.

Authors:  Senthil Selvaraj; Kenneth B Margulies
Journal:  Cardiovasc Res       Date:  2021-03-21       Impact factor: 10.787

4.  Lipids and ketones dominate metabolism at the expense of glucose control in pulmonary arterial hypertension: a hyperglycaemic clamp and metabolomics study.

Authors:  Jacob T Mey; Adithya Hari; Christopher L Axelrod; Ciarán E Fealy; Melissa L Erickson; John P Kirwan; Raed A Dweik; Gustavo A Heresi
Journal:  Eur Respir J       Date:  2020-04-09       Impact factor: 16.671

5.  Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency.

Authors:  Kim L Ho; Liyan Zhang; Cory Wagg; Rami Al Batran; Keshav Gopal; Jody Levasseur; Teresa Leone; Jason R B Dyck; John R Ussher; Deborah M Muoio; Daniel P Kelly; Gary D Lopaschuk
Journal:  Cardiovasc Res       Date:  2019-09-01       Impact factor: 10.787

6.  Remodeling of substrate consumption in the murine sTAC model of heart failure.

Authors:  Aslan Turer; Francisco Altamirano; Gabriele G Schiattarella; Herman May; Thomas G Gillette; Craig R Malloy; Matthew E Merritt
Journal:  J Mol Cell Cardiol       Date:  2019-07-21       Impact factor: 5.000

7.  Increasing mitochondrial ATP synthesis with butyrate normalizes ADP and contractile function in metabolic heart disease.

Authors:  Marcello Panagia; Huamei He; Tomas Baka; David R Pimentel; Dominique Croteau; Markus M Bachschmid; James A Balschi; Wilson S Colucci; Ivan Luptak
Journal:  NMR Biomed       Date:  2020-02-17       Impact factor: 4.044

Review 8.  Insulin resistance and heart failure during treatment with sodium glucose cotransporter 2 inhibitors: proposed role of ketone utilization.

Authors:  Yoshiyuki Hattori
Journal:  Heart Fail Rev       Date:  2020-05       Impact factor: 4.214

9.  Fueling Cardiac Hypertrophy.

Authors:  Timothy R Matsuura; Teresa C Leone; Daniel P Kelly
Journal:  Circ Res       Date:  2020-01-16       Impact factor: 17.367

10.  Ketone body can be a fuel substrate for failing heart.

Authors:  Michinari Nakamura; Junichi Sadoshima
Journal:  Cardiovasc Res       Date:  2019-09-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.